Related references
Note: Only part of the references are listed.Amifampridine for the Management of Lambert-Eaton Myasthenic Syndrome: A New Take on an Old Drug
Connie H. Yoon et al.
ANNALS OF PHARMACOTHERAPY (2020)
The Frog Motor Nerve Terminal Has Very Brief Action Potentials and Three Electrical Regions Predicted to Differentially Control Transmitter Release
Scott P. Ginebaugh et al.
JOURNAL OF NEUROSCIENCE (2020)
The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations
Pedro M. Rodriguez Cruz et al.
BRAIN (2019)
Regulation of Nociceptive Glutamatergic Signaling by Presynaptic Kv3.4 Channels in the Rat Spinal Dorsal Horn
Tanziyah Muqeem et al.
JOURNAL OF NEUROSCIENCE (2018)
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia
Donald B. Sanders et al.
MUSCLE & NERVE (2018)
New Cav2 calcium channel gating modifiers with agonist activity and therapeutic potential to treat neuromuscular disease
Man Wu et al.
NEUROPHARMACOLOGY (2018)
A-Type KV Channels in Dorsal Root Ganglion Neurons: Diversity, Function, and Dysfunction
Benjamin M. Zemel et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Reply to Meriney and Lacomis: Comment on direct aminopyridine effects on voltage-gated Ca2+ channels
Zi-Zhen Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Reported direct aminopyridine effects on voltage-gated calcium channels is a high-dose pharmacological off-target effect of no clinical relevance
Stephen D. Meriney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study
Silvia Bonanno et al.
SAGE OPEN MEDICINE (2018)
Effect of 3,4-diaminopyridine at the murine neuromuscular junction
Fiona Ng et al.
MUSCLE & NERVE (2017)
Kv3 CHANNELS: ENABLERS OF RAPID FIRING, NEUROTRANSMITTER RELEASE, AND NEURONAL ENDURANCE
Leonard K. Kaczmarek et al.
PHYSIOLOGICAL REVIEWS (2017)
Rapid State-Dependent Alteration in Kv3 Channel Availability Drives Flexible Synaptic Signaling Dependent on Somatic Subthreshold Depolarization
Matthew J. M. Rowan et al.
CELL REPORTS (2017)
Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia
Nilay Thakkar et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Aminopyridines for the treatment of neurologic disorders
Michael Strupp et al.
NEUROLOGY-CLINICAL PRACTICE (2017)
MYASTHENIA GRAVIS LAMBERT-EATON OVERLAP SYNDROME
Shin J. Oh
MUSCLE & NERVE (2016)
Clinical features of the myasthenic syndrome arising from mutations in GMPPB
Pedro M. Rodriguez Cruz et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations
D. Natera-de Benito et al.
NEUROMUSCULAR DISORDERS (2016)
Phenotypic heterogeneity in two large Roma families with a congenital myasthenic syndrome due to CHRNE 1267delG mutation. A long-term follow-up
D. Natera-de Benito et al.
NEUROMUSCULAR DISORDERS (2016)
Synapse-Level Determination of Action Potential Duration by K+ Channel Clustering in Axons
Matthew J. M. Rowan et al.
NEURON (2016)
A Novel Striated Muscle-Specific Myosin-Blocking Drug for the Study of Neuromuscular Physiology
Dante J. Heredia et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Clinical and neurophysiological response to pharmacological treatment of DOK7 congenital myasthenia in an older patient
Nanna Witting et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2015)
Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults
Peter E. Haroldsen et al.
CLINICAL THERAPEUTICS (2015)
Pharmacokinetics and safety of 3,4-diaminopyridine base in healthy Japanese volunteers
Natsuko Ishida et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Transmitter release is evoked with low probability predominately by calcium flux through single channel openings at the frog neuromuscular junction
Fujun Luo et al.
JOURNAL OF NEUROPHYSIOLOGY (2015)
A Photostable Silicon Rhodamine Platform for Optical Voltage Sensing
Yi-Lin Huang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate
Peter E. Haroldsen et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Distinct Kv Channel Subtypes Contribute to Differences in Spike Signaling Properties in the Axon Initial Segment and Presynaptic Boutons of Cerebellar Interneurons
Matthew J. M. Rowan et al.
JOURNAL OF NEUROSCIENCE (2014)
Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist
Tyler B. Tarr et al.
JOURNAL OF PHYSIOLOGY-LONDON (2014)
3,4-Diaminopyridine (amifampridine) for the treatment of Lambert-Eaton myasthenic syndrome
Sabine Lindquist et al.
EXPERT OPINION ON ORPHAN DRUGS (2014)
Potentiation of High Voltage-Activated Calcium Channels by 4-Aminopyridine Depends on Subunit Composition
Li Li et al.
MOLECULAR PHARMACOLOGY (2014)
Evaluation of a Novel Calcium Channel Agonist for Therapeutic Potential in Lambert-Eaton Myasthenic Syndrome
Tyler B. Tarr et al.
JOURNAL OF NEUROSCIENCE (2013)
Are unreliable release mechanisms conserved from NMJ to CNS?
Tyler B. Tarr et al.
TRENDS IN NEUROSCIENCES (2013)
Treatment of Nystagmus
Matthew J. Thurtell et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2012)
Spatial organization of the extracellular matrix regulates cell-cell junction positioning
Qingzong Tseng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Sparse But Highly Efficient Kv3 Outpace BKCa Channels in Action Potential Repolarization at Hippocampal Mossy Fiber Boutons
Henrik Alle et al.
JOURNAL OF NEUROSCIENCE (2011)
Single-Pixel Optical Fluctuation Analysis of Calcium Channel Function in Active Zones of Motor Nerve Terminals
Fujun Luo et al.
JOURNAL OF NEUROSCIENCE (2011)
A new micropatterning method of soft substrates reveals that different tumorigenic signals can promote or reduce cell contraction levels
Qingzong Tseng et al.
LAB ON A CHIP (2011)
3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome
Paul W. Wirtz et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Efficacy of 3,4-Diaminopyridine and Pyridostigmine in the Treatment of Lambert-Eaton Myasthenic Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
P. W. Wirtz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Aminopyridines Potentiate Synaptic and Neuromuscular Transmission by Targeting the Voltage-activated Calcium Channel β Subunit
Zi-Zhen Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Characterization of Voltage-Gated Potassium Channels in Human Neural Progenitor Cells
Grit Schaarschmidt et al.
PLOS ONE (2009)
Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine
BL Banwell et al.
NEUROMUSCULAR DISORDERS (2004)
Kv3 voltage-gated potassium channels regulate neurotransmitter release from mouse motor nerve terminals
RE Brooke et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine
C Mainero et al.
NEUROLOGY (2004)
Requirement for the synaptic protein interaction site for reconstitution of synaptic transmission by P/Q-type calcium channels
S Mochida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Calcium channels involved in neurotransmitter release at adult, neonatal and P/Q-type deficient neuromuscular junctions (Review)
FJ Urbano et al.
MOLECULAR MEMBRANE BIOLOGY (2002)
Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission
MT Flink et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Kv3 channels:: voltage-gated K+ channels designed for high-frequency repetitive firing
B Rudy et al.
TRENDS IN NEUROSCIENCES (2001)
Share Paper
